These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38666019)

  • 21. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botany of European mistletoe (Viscum album L.).
    Becker H
    Oncology; 1986; 43 Suppl 1():2-7. PubMed ID: 3808574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
    Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
    Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotechnological Potential of Different Organs of Mistletoe (
    Skrypnik L; Feduraev P; Golovin A; Maslennikov P; Belov N; Matveev M; Pungin A
    Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
    Gorter RW; van Wely M; Reif M; Stoss M
    Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (E,E)-alpha-farnesene the main substance of the volatiles of the flowers from European mistletoe (Viscum album L.).
    Bungert M; Thiel R; Goedings P; Becker H
    Z Naturforsch C J Biosci; 2002; 57(1-2):205-7. PubMed ID: 11926536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
    Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotective effects of Viscum album L. subsp. album (European misletoe) leaf extracts in myocardial ischemia and reperfusion.
    Suveren E; Baxter GF; Iskit AB; Turker AU
    J Ethnopharmacol; 2017 Sep; 209():203-209. PubMed ID: 28689799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
    Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
    BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mistletoe Eradicator - A Novel Tool for Simultaneous Mechanical and Chemical Control of Mistletoe.
    Bhat KA; Akhtar S; Dar NA; Bhat MI; Bhat FA; Rizwan R; Horielov O; Krasylenko Y
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Assessment of Biological Activities of Mistletoes for Cosmetic Applications:
    Choi SU; Kim ST; Han DG; Hwang YH; Lee KY; Kim DU; Cho KH; Park SY; Kim HC; Kim SB; Jang DJ
    J Cosmet Sci; 2019; 70(5):235-245. PubMed ID: 31596226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenolic compounds from
    Melo MNO; Oliveira AP; Wiecikowski AF; Carvalho RS; Castro JL; de Oliveira FAG; Pereira HMG; da Veiga VF; Capella MMA; Rocha L; Holandino C
    Saudi Pharm J; 2018 Mar; 26(3):311-322. PubMed ID: 29556122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
    Büssing A; Suzart K; Schweizer K
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S9-14. PubMed ID: 9179360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viscothionin purified from mistletoe (Viscum album var. coloratum Ohwi) induces insulin secretion from pancreatic beta cells.
    Park JH; Kim YN; Kim JK; Park HY; Song BS
    J Ethnopharmacol; 2019 Apr; 234():172-179. PubMed ID: 30660712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lectins in Viscum:a progress review].
    Li JQ; Yang B
    Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3551-3559. PubMed ID: 34402277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study on the effects of aqueous extracts of viscum album (mistletoe) from three host plants on hematological parameters in albino rats.
    Ladokun O; Ojezele M; Arojojoye O
    Afr Health Sci; 2015 Jun; 15(2):606-12. PubMed ID: 26124810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Anti-Inflammatory Activity of
    Nicoletti M
    Plants (Basel); 2023 Mar; 12(7):. PubMed ID: 37050086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.